NeuroPPEye

• Focus: Translational research in biomedical optics for hyperspectral imaging based quantitative fluorescence linked with an in-patient neurosurgery clinical study
• Line manager: Tom Vercauteren
• Clinical collaborator: King’s College Hospital
• Industry collaborator: Hypervision Surgical
• Salary: Grade 6, £38,826 - £45,649 per annum, including London Weighting Allowance

Job description

We are seeking a biomedical optics researcher to design and translate the next generation of hyperspectral imaging systems for surgical guidance using quantitative fluorescence. The postholder, based within the Department of Surgical & Interventional Engineering at King’s College London, will play a key role in a collaborative project with King’s College Hospital and work closely with the project’s industrial collaborator Hypervision Surgical, a recently founded King’s spin-out company. A clinical neurosurgery study has been set up to underpin this collaboration.

• Focus: Translational research on hyperspectral-based quantitative fluorescence imaging linked with a neurosurgery clinical study
• Primary supervisor: Tom Vercauteren
• Secondary supervisor: Jonathan Shapey
• Industry collaborator: Hypervision Surgical
• Funding type: Tuition fee, stipend (Home Fee status only).
• Application closing date: 11 April 2022
• Start date: June 2022

Aim of the project

This project aims at enabling wide-field and real-time quantitative assessment of tumour-specific fluorescence by designing novel deep-learning-based computational algorithms. The project will leverage a compact hyperspectral imaging (HSI) system developed by Hypervision Surgical Ltd initially designed for contrast-free imaging.

We are actively involving patients and carers to make our research on next generation neurosurgery more relevant and impactful. Early February 2022, our research scientists from King’s College London and King’s College Hospital organised a Patient and Public Involvement (PPI) meeting with support from The Brain Tumour Charity.